Related Experiment Video
Updated: May 5, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Efficacy of Bifidobacterium longum and Lactobacillus plantarum (NVP-1703) in Children With Allergic Rhinitis: A
Kyunguk Jeong1, Seok Won Jang2, Se-Ah Jeon1
1Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea.
Insights
This study found that probiotics containing Bifidobacterium longum and Lactobacillus plantarum significantly reduced allergic rhinitis symptoms and improved quality of life in children. The treatment was safe and well-tolerated, showing promising results for managing pediatric allergic rhinitis.
Area of Science:
- Immunology
- Microbiology
- Pediatrics
Background:
- Allergic rhinitis (AR) is a common condition in children.
- Probiotics show potential for AR treatment, but evidence is mixed.
- The safety and efficacy of specific probiotic strains need further investigation.
Purpose of the Study:
- To evaluate the therapeutic effects of a Bifidobacterium longum and Lactobacillus plantarum mixture (NVP-1703) in children with perennial allergic rhinitis.
- To assess the safety profile of NVP-1703 in the pediatric population.
- To investigate the impact of NVP-1703 on allergic inflammatory markers.
Main Methods:
- A randomized, double-blind, placebo-controlled trial was conducted.
- Participants included children aged 6-19 years with perennial AR.
- Treatment involved NVP-1703 (1 × 10^10 CFU/day) or placebo for 4 weeks, with symptom scores, quality of life, and inflammatory markers assessed.
Main Results:
- NVP-1703 significantly reduced total nasal symptom scores (TNSS) and nasal symptom duration scores (NSDS) compared to placebo.
- Quality of life improved, particularly regarding mouth breathing and itchy nose.
- Reduced ratios of IL-4/IL-22 and IL-5/IL-22 were observed, indicating modulation of allergic inflammation.
- No significant adverse events were reported with NVP-1703.
Conclusions:
- Oral NVP-1703 effectively improves allergic rhinitis symptoms and quality of life in children.
- The probiotic mixture modulates T helper 2 cytokine responses.
- NVP-1703 presents a safe and effective therapeutic option for pediatric perennial allergic rhinitis.
Background:
There is increasing evidence that probiotics are effective in treating allergic rhinitis (AR), while some controversies remain. This study was performed to evaluate the therapeutic effect and safety of a mixture of Bifidobacterium longum and Lactobacillus plantarum (NVP-1703) in children with AR.
Methods:
In a randomized, double-blind, placebo-controlled study, children aged 6 to 19 years with perennial AR were treated with NVP-1703 at a dose of 1 × 1010 CFU/day or placebo once a day for 4 weeks. Total nasal symptom score (TNSS), nasal symptom duration score (NSDS), quality of life (QoL), allergic inflammatory markers, and safety parameters were evaluated.
Results:
After 4 weeks of treatment, the TNSS in the NVP-1703 group significantly decreased compared to that in the placebo group (P = 0.011), both in the morning and the evening (P = 0.031 and P = 0.004, respectively). The NSDS also significantly decreased in the NVP-1703 group compared to that in the placebo group (P = 0.018). QoL scores, particularly those related to mouth breathing and itchy nose, showed a significant improvement in the NVP-1703 group compared to the placebo group. The ratios of interleukin (IL)-4/IL-22 and IL-5/IL-22 were significantly reduced in the NVP-1703 group after the treatment compared to the baseline values. No notable adverse events were reported in the NVP-1703 group.
Conclusion:
Oral administration of a mixture of B. longum and L. plantarum (NVP-1703) improved both AR symptoms and QoL in children with perennial AR, accompanied by decreases in the ratios of T helper 2 cytokines to IL-22.
Trial Registration:
Clinical Research Information Service Identifier: KCT0002661.
Related Concept Videos
Probiotics
Development of Human Microbiota
Microbiota of the Respiratory Tract

